RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+6.51%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$251M
AUM Growth
–
Cap. Flow
+$251M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
29.9%
Holding
83
New
83
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$10.2M |
| 2 |
CELG
Celgene Corp
CELG
|
$8.28M |
| 3 |
Gilead Sciences
GILD
|
$8.19M |
| 4 |
CVS Health
CVS
|
$7.66M |
| 5 |
Biogen
BIIB
|
$7.55M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 84.16% |
| 2 | Financials | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VOLC
76
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $983K | 0.38% |
+45,000
| New | +$983K |
|
|
LUMO
77
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $880K | 0.34% |
+4,444
| New | +$880K |
|
|
MDRX
78
DELISTED
Veradigm Inc. Common Stock
MDRX
| $850K | 0.33% |
+55,000
| New | +$850K |
|
79
Lexicon Pharmaceuticals
LXRX
$392M
| $540K | 0.21% |
+42,857
| New | +$540K |
|
80
Madrigal Pharmaceuticals
MDGL
$9.7B
| $524K | 0.21% |
+2,857
| New | +$524K |
|
|
NVDQ
81
DELISTED
Novadaq Technologies Inc.
NVDQ
| $412K | 0.16% |
+25,000
| New | +$412K |
|
|
ANTH
82
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $366K | 0.14% |
+14,912
| New | +$366K |
|
|
ECYT
83
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $267K | 0.1% |
+25,000
| New | +$267K |
|